TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Cann Group ( (AU:CAN) ) just unveiled an announcement.
Cann Group Limited announced a positive EBITDA for August 2025, marking a significant milestone since the commissioning of its Mildura facility in 2022. The company’s growth is driven by strong B2B flower sales, expansion of its Botanitech product range, and increasing export opportunities, particularly in Europe. Cann is also enhancing its product portfolio with new offerings and has secured additional R&D funding, while progressing its refinancing initiatives to support future growth.
More about Cann Group
Cann Group Limited operates in the cannabis industry, focusing on the cultivation and production of medicinal cannabis products. The company is known for its B2B flower sales and innovative product lines such as the Botanitech range, with a market focus on both domestic and international opportunities.
Average Trading Volume: 1,406,994
Technical Sentiment Signal: Sell
Current Market Cap: A$7.3M
See more data about CAN stock on TipRanks’ Stock Analysis page.